Anticoagulant Counter Ion Impact on Bioanalytical LC–MS/MS Assay Performance: Additional Validation Required?
Authors:
- 10 November 2011
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 3 (21) , 2389-2391
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Anticoagulant Counter Ion Impact on Bioanalytical LC–MS/MS Assays: Results from Discussions and Experiments Within The European Bioanalysis ForumBioanalysis, 2011
- Conference Report: from Challenges to SolutionsBioanalysis, 2011
- A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditionsClinical Therapeutics, 2009
- Impact of Plasma and Whole-Blood Anticoagulant Counter Ion Choice on Drug Stability and Matrix Effects During BioanalysisBioanalysis, 2009
- The 2nd Calibration and Validation Group Workshop on Recent Issues in Good Laboratory Practice BioanalysisBioanalysis, 2009
- Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding AssaysPharmaceutical Research, 2007